Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Nucl Med Commun ; 42(6): 625-632, 2021 Jun 01.
Article in English | MEDLINE | ID: mdl-33625186

ABSTRACT

OBJECTIVE: High-grade gliomas (HGGs) carry dismal prognosis with survival typically reported as less than a year. We explored the predictive value of qualitative and quantitative evaluations of post-treatment 99m-technetium-labelled methoxyisobutylisonitrile (99mmTc-MIBI) brain single-photon emission computed tomography-computed tomography (SPECT/CT) tumor uptake in relation to overall survival (OS) in patients with HGG. METHODS: Thirty patients with pathologically or radiologically documented high-grade glioma (HGG) were prospectively recruited for this study (24 male, 6 female; mean age 43 ± 14 years). All patients had a clinical or radiological suspicion of residual/recurrent tumor after initial therapy. 99mTc-MIBI brain SPECT/CT scanning was performed, and the scans were evaluated qualitatively on a five-point probability score (1-5, scores ≥3 considered positive for residual/recurrent tumor); and quantitively via drawing volumes of interest (VOI) on the suspected lesions and normal contralateral brain tissue. All patients were followed up for 1 year or till death. RESULTS: Positive visual MIBI results were associated with poor survival. Among 10 patients with negative MIBI scores, only two patients died (OS = 75%), while 11/20 patients reported positive on MIBI died, with a median survival of 9 months (OS = 14.5%; P = 0.03). All patients with active isocontour volume ≤1.96 cm3 were alive at the end of the study, compared to a median survival of 9 months and OS of 12% for patients with an isocontour volume of >1.97% (P = 0.003). CONCLUSION: In patients with HGG, post-therapy brain SPECT/CT with 99mTc-MIBI can provide useful prognostic information.


Subject(s)
Glioma , Single Photon Emission Computed Tomography Computed Tomography , Technetium Tc 99m Sestamibi , Adult , Aged , Brain Neoplasms , Female , Humans , Middle Aged , Prognosis
2.
Clin Nucl Med ; 42(11): 855-856, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28872553

ABSTRACT

The presence of ectopic thyroid tissue in 2 or more different sites is rare. A 12-year-old girl presented with midline anterior neck swelling in the infrahyoid region with subclinical hypothyroidism. Thyroid scanning with Tc-pertechnetate was performed, and SPECT/CT was ordered for further evaluation. Two hyperdense lesions demonstrating intense radiotracer uptake were seen in the midline at the base of the tongue and infrahyoid neck. We emphasis the role of hybrid SPECT/CT for characterization and localization of suspected ectopic thyroid tissue.


Subject(s)
Single Photon Emission Computed Tomography Computed Tomography , Thyroid Dysgenesis/diagnostic imaging , Biological Transport , Child , Female , Humans , Hypothyroidism/complications , Sodium Pertechnetate Tc 99m/metabolism , Thyroid Dysgenesis/complications , Thyroid Dysgenesis/metabolism , Thyroid Dysgenesis/pathology
SELECTION OF CITATIONS
SEARCH DETAIL